Short-Term Studies of MDL 19,660-induced Canine Thrombocytopenia

Abstract

After 2 days of dosing, platelet counts progressively declined in dogs treated orally with 30 mg/kg/day of the antidepressant compound MDL 19,660 for 8 days. Accompanying the decrease in platelet counts was an increase in both large and vacuolated degenerating platelets. Upon cessation of dosing, the platelet counts returned to levels equal to or exceeding predosing levels within 4–7 days. Co-administration with aspirin, a known antiaggregating agent, had no protective effect on the drug-induced thrombocytopenia. In vitro testing of normal canine platelets in the presence of MDL 19,660 further revealed that spontaneous aggregation did not occur and that ADP-induced aggregation was inhibited. Drug-related platelet loss was also not prevented by the co-administration of prednisone, a steroid with immunosuppressive effects and inhibitory properties against reticuloendothelial cell phagocytosis of platelets. The results of the present investigation indicate that MDL 19,660 may produce in the dog a reversible thrombocytopenia in the form of vacuolar degeneration and subsequent destruction of the platelet by means other than aggregation or steroid-responsive mechanisms.

Keywords

Platelet vacuolation reversibility antiaggregation aspirin prednisone

References

Bell

Tomasulo

Alving

, and Duffy

(1976). Thrombocytopenia occurring during the administration of heparin. Ann. Int. Med. 85: 155–160.

Branehog

and Weinfeld

(1974). Platelet survival and platelet production in idiopathic thrombocytopenia purpura (ITP) before and during treatment with corticosteroids. Scand. J. Haematol. 12: 69–79.

Claman

(1972). Corticosteroids and lymphoid cells. New Eng. J. Med. 287: 388–397.

Corash

Chen

Levin

Baker

, and Mok

(1987). Regulation of thrombopoiesis: effects of the degree of thrombocytopenia on megakaryocyte ploidy and platelet volume. Blood 70: 177–185.

Dale

and Balow

(1976). Glucocorticosteroid therapy: Mechanisms of action and clinical considerations. NIH conference, AS Fauci (moderator). Ann. Int. Med. 84: 304–315.

Damus

and Salzman

(1972). Disseminated intravascular coagulation. Arch. Surg. 104: 262–265.

Dodds

(1971). Hemorrhagic disorders. In: Current Veterinary Therapy, Kirk

(ed). WB Saunders Company, Philadelphia, pp. 252.

Folts

Gallagher

, and Rowe

(1982). Blood flow reductions in stenosed canine coronary arteries: Vasospasm or platelet aggregation? Circulation 65: 248–255.

Gandolfo

Biancolella

Bongiovanni

Ferri

Biondi

, and Malagoli

(1974). Morphologic and functional alterations of platelets induced by inhibitors of platelet aggregation. In: Platelet Aggregation and Drugs, Caprino

and Rossi

(eds). Academic Press, London, pp. 169–184.

10.

Greene

(1975). Disseminated intravascular coagulation in the dog: a review. J. Am. Anim. Hosp. Assoc. 11: 674–687.

11.

Kane

(1987). The bis(tricyclohexylstannyl) sulfide thionation of 3H-1,2,4-triazol-3-ones. Synthesis 912–914.

12.

Kane

Dudley

Sorensen

, and Miller

(1988). 2,4-Dihydro-3H-1,2,4-triazol-3-thiones as potential antidepressant agents. J. Med. Chem. 31: 1253–1258.

13.

Kocsis

Hernandovich

Silver

, and Ingerman

(1973). Duration of inhibition of platelet prostaglandin formation and aggregation by ingested aspirin or indomethacin. Prostaglandins 3: 141–144.

14.

Landell

(1974). Coagulation and hemostasis. In: Clinical Diagnosis By Laboratory Methods, Davidsohn

and Henry

(eds). WB Saunders Co, Philadelphia, pp. 414–448.

15.

Levin

and Bessman

(1983). The inverse relation between platelet volume and platelet number. Abnormalities in hematologic disease and evidence that platelet size does not correlate with platelet age. J. Lab. Clin. Med. 101: 295–307.

16.

Luft

(1961). Improvements in epoxy resin embedding methods. J. Biophys. Biochem. Cytol. 9: 409–414.

17.

Mattson

(1985). Use of scanning electron microscopy to study structural-functional relationships in normal and diseased platelets. In: Scanning Electron Microscopy, Johari

(ed). Amf O'hare, Chicago, pp. 357–391.

18.

Mattson

Borgerding

, and Craft

(1977). Fixation of platelets for scanning and transmission electron microscopy. Stain Technology 52: 151–158.

19.

Penington

(1981). Formation of platelets. In: Platelets in Biology and Pathology-2, Gordon

(ed). Elsevier/North Holland Press, Amsterdam, pp. 19–40.

20.

Rodman

(1971). The morphologic basis of platelet function. In: The Platelet, Brinkhous

Shermer

, and Mostofi

(eds). The Williams and Wilkins Company, Baltimore, pp. 55–70.

21.

Savage

Hanson

, and Harker

(1988). Selective decrease in platelet dense granule adenine nucleotides during recovery from acute experimental thrombocytopenia and ensuing thrombocytosis in baboons. Brit. J. Haematol. 68: 75–82.

22.

Sorensen

Zwolshen

Dudley

Kane

, and Miller

(1987). An electrophysiological comparison of despramine and the potential antidepressant, MDL 19,660. Soc. Neurosci. 13: 885 (ABSTRACT).

23.

Szczeklik

Gryglewski

Grodzinska

Musial

Serwonska

, and Marcinkiewicz

(1979). Platelet aggregability, thromboxane a₂ and malonaldehyde formation following administration of aspirin to man. Thromb. Res. 15: 405–413.

24.

Tong

Seth

, and Penington

(1987). Proplatelets and stress platelets. Blood 69: 522–528.

25.

Ulutin

(1976). The effect of antiaggregating agents on platelets. In: The Platelets. Kagit ve Basim Isleri AS, Istanbul, pp. 176–205.

26.

Ulutin

(1976a). Platelet adhesion, aggregation and release mechanism In: The Platelets. Kagit ve Basim Isleri AS, Istanbul, pp. 112–157.

27.

Webb

and Winkelstein

(1980). Immunosuppression and immunopotentiation. In: Basic and Clinical Immunology, Fundenberg

Sites

Caldwell

, and Wells

(eds). Lange Medical Publications, Los Altos, pp. 316–317.

28.

White

(1979). Current concepts of platelet structure. Am. J. Clin. Pathol. 71: 363–378.

29.

White

(1987). Views of the platelet cytoskeleton at rest and at work. Ann. NY Acad. Sci. 509: 156–176.

30.

Wilkins

Hurvitz

, and Dodds-Laffin

(1973). Immunologically mediated thrombocytopenia in the dog. J.A.V.M.A. 163: 277–282.

31.

Wintrobe

Lee

Boggs

Bithell

Athens

, and Foerster

(eds) (1974). Quantitative variations of platelets in disease; thrombocytopenia and thrombocytosis. In: Clinical Hematology. Lea and Febiger, Philadelphia, pp. 1085.